Cardiometabolic Diseases: Molecular Biomarkers and Treatment Strategies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 59
Special Issue Editors
Interests: cardiology; vascular diseases; endocrinology; diabetes mellitus; igf-1; metabolic syndrome
Interests: cardiovascular diseases; metabolic syndrome; obesity; endocrinology
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue on Cardiometabolic Disease: Molecular Biomarkers and Treatment Strategies in Biomedicines.
Cardiometabolic disease (CMD) is the leading global cause of human mortality and morbidity worldwide. Development of CMD is a particularly complex pathophysiological condition that involves an unclear network of metabolic and hormonal dysregulation. This compound pathology comprises insulin impairment, alterations in lipid status, hypertension, obesity, and chronic low-grade inflammation. Nevertheless, this is a significant field of medicine that has been at the center of research due to its global prevalence. Clarification of molecular mechanisms and the development of optimized diagnostic and treatment approaches for patients with this condition are essential for achieving a prosperous long-term outcome. Given that traditional biomarkers have certain limitations, for instance, relative sensitivity and reliability in particular clinical circumstances, the management of additional and individual biomarkers and treatment strategies is imperative for present-day medicine. Novel research related to the evaluation of CMD molecular biomarkers is an important topic that could improve timely treatment and enhance positive outcomes.
This Special Issue aims to highlight biomarkers for CMDs, together with omics technologies and analytical approaches that offer better-quality information for risk assessment, diagnosis, prognosis, and treatment management. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the recent discoveries related to the use of biomarkers for the advanced management of CMDs. We look forward to receiving your valuable contributions.
Dr. Jelena Radovanović
Dr. Sonja Zafirovic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiometabolic disease
- obesity
- diabetes mellitus
- insulin resistance
- lipid status
- biomarkers
- hypertension
- metabolic dysregulation
- personalized therapy
- omics technologies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
